drugset / Trial / NCT04196855
Study of Teriparatide in Stress Fracture Healing
Phase 3
Unknown
136 enrolled
University of East Anglia
Clinical Research and Trials Unit (Norfolk & Norwich University Hospital, UK) · collabDarlington Memorial Hospital · collabMinistry of Defence, United Kingdom · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
Investigation into the use of teriparatide in the treatment of stress fractures. Primary outcome is healing on MRI, secondary outcomes are pain, time spent in rehabilitation and future stress fractures. This study will help the investigators understand how to treat stress fractures in the future.
Timeline
- Start
- 2019-12-23
- Primary completion
- 2022-06
- Completion
- 2022-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Teriparatide | Protein / enzyme biologic | 20 ug | — |
Indications
No indication recorded.